Cargando…

Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient

BACKGROUND: High quality genetic material is an essential pre-requisite when analyzing gene expression using microarray technology. Peripheral blood mononuclear cells (PBMC) are frequently used for genomic analyses, but several factors can affect the integrity of nucleic acids prior to their extract...

Descripción completa

Detalles Bibliográficos
Autores principales: Corkum, Christopher P., Ings, Danielle P., Burgess, Christopher, Karwowska, Sylwia, Kroll, Werner, Michalak, Tomasz I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549105/
https://www.ncbi.nlm.nih.gov/pubmed/26307036
http://dx.doi.org/10.1186/s12865-015-0113-0
_version_ 1782387270882426880
author Corkum, Christopher P.
Ings, Danielle P.
Burgess, Christopher
Karwowska, Sylwia
Kroll, Werner
Michalak, Tomasz I.
author_facet Corkum, Christopher P.
Ings, Danielle P.
Burgess, Christopher
Karwowska, Sylwia
Kroll, Werner
Michalak, Tomasz I.
author_sort Corkum, Christopher P.
collection PubMed
description BACKGROUND: High quality genetic material is an essential pre-requisite when analyzing gene expression using microarray technology. Peripheral blood mononuclear cells (PBMC) are frequently used for genomic analyses, but several factors can affect the integrity of nucleic acids prior to their extraction, including the methods of PBMC collection and isolation. Due to the lack of the relevant data published, we compared the Ficoll-Paque density gradient centrifugation and BD Vacutainer cell preparation tube (CPT) protocols to determine if either method offered a distinct advantage in preparation of PBMC-derived immune cell subsets for their use in gene expression analysis. We evaluated the yield and purity of immune cell subpopulations isolated from PBMC derived by both methods, the quantity and quality of extracted nucleic acids, and compared gene expression in PBMC and individual immune cell types from Ficoll and CPT isolation protocols using Affymetrix microarrays. RESULTS: The mean yield and viability of fresh PBMC acquired by the CPT method (1.16 × 10(6) cells/ml, 93.3 %) were compatible to those obtained with Ficoll (1.34 × 10(6) cells/ml, 97.2 %). No differences in the mean purity, recovery, and viability of CD19+ (B cells), CD8+ (cytotoxic T cells), CD4+ (helper T cell) and CD14+ (monocytes) positively selected from CPT- or Ficoll-isolated PBMC were found. Similar quantities of high quality RNA and DNA were extracted from PBMC and immune cells obtained by both methods. Finally, the PBMC isolation methods tested did not impact subsequent recovery and purity of individual immune cell subsets and, importantly, their gene expression profiles. CONCLUSIONS: Our findings demonstrate that the CPT and Ficoll PBMC isolation protocols do not differ in their ability to purify high quality immune cell subpopulations. Since there was no difference in the gene expression profiles between immune cells obtained by these two methods, the Ficoll isolation can be substituted by the CPT protocol without conceding phenotypic changes of immune cells and compromising the gene expression studies. Given that the CPT protocol is less elaborate, minimizes cells’ handling and processing time, this method offers a significant operating advantage, especially in large-scale clinical studies aiming at dissecting gene expression in PBMC and PBMC-derived immune cell subpopulations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12865-015-0113-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4549105
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45491052015-08-26 Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient Corkum, Christopher P. Ings, Danielle P. Burgess, Christopher Karwowska, Sylwia Kroll, Werner Michalak, Tomasz I. BMC Immunol Methodology BACKGROUND: High quality genetic material is an essential pre-requisite when analyzing gene expression using microarray technology. Peripheral blood mononuclear cells (PBMC) are frequently used for genomic analyses, but several factors can affect the integrity of nucleic acids prior to their extraction, including the methods of PBMC collection and isolation. Due to the lack of the relevant data published, we compared the Ficoll-Paque density gradient centrifugation and BD Vacutainer cell preparation tube (CPT) protocols to determine if either method offered a distinct advantage in preparation of PBMC-derived immune cell subsets for their use in gene expression analysis. We evaluated the yield and purity of immune cell subpopulations isolated from PBMC derived by both methods, the quantity and quality of extracted nucleic acids, and compared gene expression in PBMC and individual immune cell types from Ficoll and CPT isolation protocols using Affymetrix microarrays. RESULTS: The mean yield and viability of fresh PBMC acquired by the CPT method (1.16 × 10(6) cells/ml, 93.3 %) were compatible to those obtained with Ficoll (1.34 × 10(6) cells/ml, 97.2 %). No differences in the mean purity, recovery, and viability of CD19+ (B cells), CD8+ (cytotoxic T cells), CD4+ (helper T cell) and CD14+ (monocytes) positively selected from CPT- or Ficoll-isolated PBMC were found. Similar quantities of high quality RNA and DNA were extracted from PBMC and immune cells obtained by both methods. Finally, the PBMC isolation methods tested did not impact subsequent recovery and purity of individual immune cell subsets and, importantly, their gene expression profiles. CONCLUSIONS: Our findings demonstrate that the CPT and Ficoll PBMC isolation protocols do not differ in their ability to purify high quality immune cell subpopulations. Since there was no difference in the gene expression profiles between immune cells obtained by these two methods, the Ficoll isolation can be substituted by the CPT protocol without conceding phenotypic changes of immune cells and compromising the gene expression studies. Given that the CPT protocol is less elaborate, minimizes cells’ handling and processing time, this method offers a significant operating advantage, especially in large-scale clinical studies aiming at dissecting gene expression in PBMC and PBMC-derived immune cell subpopulations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12865-015-0113-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-26 /pmc/articles/PMC4549105/ /pubmed/26307036 http://dx.doi.org/10.1186/s12865-015-0113-0 Text en © Corkum et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Corkum, Christopher P.
Ings, Danielle P.
Burgess, Christopher
Karwowska, Sylwia
Kroll, Werner
Michalak, Tomasz I.
Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title_full Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title_fullStr Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title_full_unstemmed Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title_short Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT(™)) and standard density gradient
title_sort immune cell subsets and their gene expression profiles from human pbmc isolated by vacutainer cell preparation tube (cpt(™)) and standard density gradient
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549105/
https://www.ncbi.nlm.nih.gov/pubmed/26307036
http://dx.doi.org/10.1186/s12865-015-0113-0
work_keys_str_mv AT corkumchristopherp immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient
AT ingsdaniellep immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient
AT burgesschristopher immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient
AT karwowskasylwia immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient
AT krollwerner immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient
AT michalaktomaszi immunecellsubsetsandtheirgeneexpressionprofilesfromhumanpbmcisolatedbyvacutainercellpreparationtubecptandstandarddensitygradient